...
机译:肺癌1(TSLC1)表达中抑癌基因的下调与结肠癌患者预后不良相关
Department of Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, People’s Republic of China;
Department of Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, People’s Republic of China;
Department of Pathology, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, People’s Republic of China;
Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, People’s Republic of China;
Department of Oncology, The Fourth Affiliated Hospital of Harbin Medical University, 37 Yiyuan Street, Harbin, 150001, People’s Republic of China;
Tumor suppressor in lung cancer 1; Colon cancer; Prognosis; Human;
机译:肺癌1(TSLC1)表达中抑癌基因的下调与结肠癌患者预后不良有关。
机译:肺癌中肿瘤抑制因子1的丢失/下调与肿瘤的进展有关,是卵巢癌预后不良的生物标志。
机译:脑膜瘤中肺癌1(TSLC1)表达中肿瘤抑制因子的丧失与恶性程度增加和患者生存率降低相关。
机译:非小细胞肺癌患者肿瘤表征和预后的辐射瘤生物标志物的发展
机译:配对框基因5作为功能性肿瘤抑制因子的表观遗传学鉴定与胃癌患者预后不良相关。
机译:microRNA-124的下调与肺癌患者的肿瘤转移和预后不良相关
机译:肺癌1中肿瘤抑制因子的表达下调与肿瘤进展相关,是卵巢癌预后不良的生物标志物